BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Potter AJ, Rabinovitch PS. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs. Mutat Res. 2005;572:27-44. [PMID: 15790488 DOI: 10.1016/j.mrfmmm.2004.11.018] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Rello-Varona S, Gámez A, Moreno V, Stockert JC, Cristóbal J, Pacheco M, Cañete M, Juarranz A, Villanueva A. Metaphase arrest and cell death induced by etoposide on HeLa cells. Int J Biochem Cell Biol 2006;38:2183-95. [PMID: 16931106 DOI: 10.1016/j.biocel.2006.06.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
2 Wang H, Feng J, Zhou T, Wei L, Zhou J. P-3F, a microtubule polymerization inhibitor enhances P53 stability through the change in localization of RPS27a. The International Journal of Biochemistry & Cell Biology 2017;92:53-62. [DOI: 10.1016/j.biocel.2017.09.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 Ho P, Chou C, Kuo Y, Tu L, Yeh S. Taiwanin A induced cell cycle arrest and p53-dependent apoptosis in human hepatocellular carcinoma HepG2 cells. Life Sciences 2007;80:493-503. [DOI: 10.1016/j.lfs.2006.10.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
4 Rocha JC, Busatto FF, de Souza LK, Saffi J. Influence of nucleotide excision repair on mitoxantrone cytotoxicity. DNA Repair 2016;42:33-43. [DOI: 10.1016/j.dnarep.2016.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
5 Zuma AA, Cavalcanti DP, Maia MC, de Souza W, Motta MCM. Effect of topoisomerase inhibitors and DNA-binding drugs on the cell proliferation and ultrastructure of Trypanosoma cruzi. International Journal of Antimicrobial Agents 2011;37:449-56. [DOI: 10.1016/j.ijantimicag.2010.11.031] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
6 Bao L, Haque A, Jackson K, Hazari S, Moroz K, Jetly R, Dash S. Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model. Am J Pathol 2011;178:838-52. [PMID: 21281816 DOI: 10.1016/j.ajpath.2010.10.029] [Cited by in Crossref: 89] [Cited by in F6Publishing: 87] [Article Influence: 8.1] [Reference Citation Analysis]
7 Xie S, Hu G, Zhang Z, Xu M, Ji B. Anti-tumour effects of HL-37, a novel anthracene derivative, in-vivo and in-vitro. Journal of Pharmacy and Pharmacology 2008;60:213-9. [DOI: 10.1211/jpp.60.2.0010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
8 Bennett CA, Winters AC, Barretto NN, Hemenway CS. Molecular targeting of MLL-rearranged leukemia cell lines with the synthetic peptide PFWT synergistically enhances the cytotoxic effect of established chemotherapeutic agents. Leuk Res 2009;33:937-47. [PMID: 19232721 DOI: 10.1016/j.leukres.2009.01.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
9 Saleh EM. Inhibition of topoisomerase IIα sensitizes FaDu cells to ionizing radiation by diminishing DNA repair. Tumour Biol 2015;36:8985-92. [PMID: 26081617 DOI: 10.1007/s13277-015-3587-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
10 Raymond AA, Benhamouche S, Neaud V, Di Martino J, Javary J, Rosenbaum J. Reptin regulates DNA double strand breaks repair in human hepatocellular carcinoma. PLoS One 2015;10:e0123333. [PMID: 25875766 DOI: 10.1371/journal.pone.0123333] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
11 Direcks WG, Berndsen SC, Proost N, Peters GJ, Balzarini J, Spreeuwenberg MD, Lammertsma AA, Molthoff CF. [18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study. Br J Cancer 2008;99:481-7. [PMID: 18665170 DOI: 10.1038/sj.bjc.6604523] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
12 Xu S, Sun G, Shen Y, Peng W, Wang H, Wei W. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines. Acta Pharmacologica Sinica 2007;28:869-78. [DOI: 10.1111/j.1745-7254.2007.00564.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
13 Rodphon W, Laohapaisan P, Supantanapong N, Reamtong O, Ngiwsara L, Lirdprapamongkol K, Thongsornkleeb C, Khunnawutmanotham N, Tummatorn J, Svasti J, Ruchirawat S. Synthesis of Isocryptolepine-Triazole Adducts and Evaluation of Their Cytotoxic Activity. ChemMedChem 2021. [PMID: 34610210 DOI: 10.1002/cmdc.202100554] [Reference Citation Analysis]
14 Xu SP, Sun GP, Shen YX, Wei W, Peng WR, Wang H. Antiproliferation and apoptosis induction of paeonol in HepG2 cells. World J Gastroenterol 2007; 13(2): 250-256 [PMID: 17226904 DOI: 10.3748/wjg.v13.i2.250] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 39] [Article Influence: 2.3] [Reference Citation Analysis]
15 Brel V, Annereau J, Vispé S, Kruczynski A, Bailly C, Guilbaud N. Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II. Biochemical Pharmacology 2011;82:1843-52. [DOI: 10.1016/j.bcp.2011.08.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
16 Salmand PA, Jungas T, Fernandez M, Conter A, Christians ES. Mouse Heat-Shock Factor 1 (HSF1) Is Involved in Testicular Response to Genotoxic Stress Induced by Doxorubicin1. Biology of Reproduction 2008;79:1092-101. [DOI: 10.1095/biolreprod.108.070334] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
17 Bair JS, Palchaudhuri R, Hergenrother PJ. Chemistry and Biology of Deoxynyboquinone, a Potent Inducer of Cancer Cell Death. J Am Chem Soc 2010;132:5469-78. [DOI: 10.1021/ja100610m] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
18 Xie SQ, Zhang ZQ, Hu GQ, Xu M, Ji BS. HL-37, a novel anthracene derivative, induces Ca(2+)-mediated apoptosis in human breast cancer cells. Toxicology 2008;254:68-74. [PMID: 18948164 DOI: 10.1016/j.tox.2008.09.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
19 Alpay K, Farshchian M, Tuomela J, Sandholm J, Aittokallio K, Siljamäki E, Kallio M, Kähäri VM, Hietanen S. Inhibition of c-Abl kinase activity renders cancer cells highly sensitive to mitoxantrone. PLoS One 2014;9:e105526. [PMID: 25148385 DOI: 10.1371/journal.pone.0105526] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
20 Mi J, Zhang X, Rabbani ZN, Liu Y, Reddy SK, Su Z, Salahuddin FK, Viles K, Giangrande PH, Dewhirst MW, Sullenger BA, Kontos CD, Clary BM. RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin. Mol Ther 2008;16:66-73. [PMID: 17912235 DOI: 10.1038/sj.mt.6300320] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
21 Tokalov SV, Abramyuk AM, Abolmaali ND. Protection of p53 wild type cells from taxol by genistein in the combined treatment of lung cancer. Nutr Cancer 2010;62:795-801. [PMID: 20661829 DOI: 10.1080/01635581003605912] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
22 Prasad RY, Wallace K, Daniel KM, Tennant AH, Zucker RM, Strickland J, Dreher K, Kligerman AD, Blackman CF, Demarini DM. Effect of treatment media on the agglomeration of titanium dioxide nanoparticles: impact on genotoxicity, cellular interaction, and cell cycle. ACS Nano 2013;7:1929-42. [PMID: 23387956 DOI: 10.1021/nn302280n] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 9.6] [Reference Citation Analysis]
23 Hodkinson PS, Elliott T, Wong WS, Rintoul RC, Mackinnon AC, Haslett C, Sethi T. ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinase. Cell Death Differ 2006;13:1776-88. [DOI: 10.1038/sj.cdd.4401849] [Cited by in Crossref: 94] [Cited by in F6Publishing: 84] [Article Influence: 5.9] [Reference Citation Analysis]
24 Sugawara K, Kadoya T, Kuramitz H. Monitoring of the interaction between U937 cells and electroactive daunomycin with an arginine-rich peptide. Bioelectrochemistry 2015;105:95-102. [DOI: 10.1016/j.bioelechem.2015.05.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
25 Leclerc X, Danos O, Scherman D, Kichler A. A comparison of synthetic oligodeoxynucleotides, DNA fragments and AAV-1 for targeted episomal and chromosomal gene repair. BMC Biotechnol 2009;9:35. [PMID: 19379497 DOI: 10.1186/1472-6750-9-35] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
26 Foroodi F, Duivenvoorden WC, Singh G. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells. Anticancer Drugs 2009;20:115-22. [PMID: 19209028 DOI: 10.1097/CAD.0b013e32831c14ec] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
27 Kolb RH, Greer PM, Cao PT, Cowan KH, Yan Y. ERK1/2 signaling plays an important role in topoisomerase II poison-induced G2/M checkpoint activation. PLoS One 2012;7:e50281. [PMID: 23166842 DOI: 10.1371/journal.pone.0050281] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
28 Hawtin RE, Stockett DE, Wong OK, Lundin C, Helleday T, Fox JA. Homologous recombination repair is essential for repair of vosaroxin-induced DNA double-strand breaks. Oncotarget 2010;1:606-19. [PMID: 21317456 DOI: 10.18632/oncotarget.101106] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
29 Chang JF, Hsu JL, Sheng YH, Leu WJ, Yu CC, Chan SH, Chan ML, Hsu LC, Liu SP, Guh JH. Phosphodiesterase Type 5 (PDE5) Inhibitors Sensitize Topoisomerase II Inhibitors in Killing Prostate Cancer Through PDE5-Independent Impairment of HR and NHEJ DNA Repair Systems. Front Oncol 2018;8:681. [PMID: 30705876 DOI: 10.3389/fonc.2018.00681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
30 Tan HH, Porter AG. DNA methyltransferase I is a mediator of doxorubicin-induced genotoxicity in human cancer cells. Biochemical and Biophysical Research Communications 2009;382:462-7. [DOI: 10.1016/j.bbrc.2009.03.065] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]